// STATE LEGISLATION TRACKER

Washington SB 5167: Making 2025-2027 fiscal biennium operating appropriations.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Washington
Bill: SB 5167
Filed: 2025-01-08
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Washington SB 5167 is the state operating budget for the 2025-2027 biennium, with supplemental operating budget changes for 2023-2025. Based on the title and available subject information, it does not appear to directly change peptide access, prescribing, compounding, telehealth, NP/naturopath scope, controlled substances, or prescription monitoring rules.

Key Points

No clear peptide-specific policy change appears from the title or subjects.
This is a broad budget bill, not a prescribing or compounding regulation bill.
Peptide users and clinicians should not expect direct access changes from this bill alone.

What to Watch For

Note Budget bills can fund health agencies, but no peptide-specific change is clear from the provided information.

Note Watch agency budgets separately if pharmacy, medical board, or telehealth enforcement capacity changes.

Where the Bill Stands

The bill passed the Legislature and was partially vetoed by the Governor on May 20, 2025, becoming Chapter 424, 2025 Laws.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws